Pomalidomide-C6-NH2?hydrochloride Chemical Properties

storage temp. 

2-8°C

solubility 

DMSO: Soluble
Methanol: Soluble

form 

Solid

color 

Light yellow to yellow

InChI

1S/C19H24N4O4.ClH/c20-10-3-1-2-4-11-21-13-7-5-6-12-16(13)19(27)23(18(12)26)14-8-9-15(24)22-17(14)25;/h5-7,14,21H,1-4,8-11,20H2,(H,22,24,25);1H

InChIKey

PBGMRXNTLPSDNR-UHFFFAOYSA-N

SMILES

O=C(C(CC1)N(C2=O)C(C3=C2C=CC=C3NCCCCCCN)=O)NC1=O.Cl

Safety Information

WGK Germany 

WGK 3

Storage Class

6.1C - Combustible acute toxic Cat.3
toxic compounds or compounds which causing chronic effects

Hazard Classifications

Repr. 1B

Pomalidomide-C6-NH2?hydrochloride Usage And Synthesis

Uses

Thalidomide-NH-C6-NH2 hydrochloride is a synthesized E3 ligase ligand-linker conjugate that incorporates the Thalidomide based cereblon ligand and a linker used in PROTAC technology[1].

reaction suitability

reactivity: carboxyl reactive
reagent type: ligand-linker conjugate

IC 50

Cereblon

References

[1] Sato T, et al. Cereblon-Based Small-Molecule Compounds to Control Neural Stem Cell Proliferation in Regenerative Medicine.?Front Cell Dev Biol. 2021;9:629326. Published 2021 Mar 11. DOI:10.3389/fcell.2021.629326
[2] Nalawansha DA, et al. PROTACs: An Emerging Therapeutic Modality in Precision Medicine. Cell Chem Biol. 2020;27(8):998-985. DOI:10.7554/eLife.57277
[3] ZHIQIANG SUN . Discovery of pomalidomide-based PROTACs for selective degradation of histone deacetylase 8[J]. European Journal of Medicinal Chemistry, 2022, 239: Article 114544. DOI: 10.1016/j.ejmech.2022.114544

Pomalidomide-C6-NH2?hydrochloride(2375194-37-7)Related Product Information

• E3 ligase Ligand-Linker Conjugates 49
• Pomalidomide-C6-PEG1-C3-PEG1-butyl iodide
• Pomalidomide-C6-PEG3-butyl iodide
• E3 ligase Ligand-Linker Conjugates 55
• 1H-Isoindole-1,3(2H)-dione, 4-[(2-aminoethyl)amino]-2-(2,6-dioxo-3-piperidinyl)-, hydrochloride (1:1)
• Pomalidomide-6-2-2-6-N3
• Pomalidomide-amido-C1-Br
• Nonanoic acid, 9-[[2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-1,3-dioxo-1H-isoindol-4-yl]amino]-
• Octanoic acid, 8-[[2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-1,3-dioxo-1H-isoindol-4-yl]amino]-
• 4-[(8-Aminooctyl)amino]-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione HCl
• POMALIDOMIDE-C9-CO2H
• Butanoic acid, 4-[[2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-1,3-dioxo-1H-isoindol-4-yl]amino]-
• 4-[(2-Aminoethyl)amino]-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione HCl
• Pomalidomide-C3-NH2
• Heptanoic acid, 7-[[2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-1,3-dioxo-1H-isoindol-4-yl]amino]-
• Pomalidomide 4'-alkylC5-acid
• 4-[(4-Aminobutyl)amino]-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione HCl
• β-Alanine, N-[2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-1,3-dioxo-1H-isoindol-4-yl]-